Omega-3
Natural health product licensed in Canada
- Licence holder
- 1952157 Ontario Inc.
- NPN or DIN-HM
- 80068622
- Status
- Active licence
- Licence date
- 18 April 2016
- Revision date
- 25 April 2017
- Form
- Capsule, molle
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Huile de poisson Source : Clupeidae - en entier Potency : 100 milligramme Docosahexaenoic acid | 500 milligramme | Not calculated |
| Huile de poisson Source : Engraulidae - en entier Potency : 100 milligramme Docosahexaenoic acid | 500 milligramme | Not calculated |
| Huile de poisson Source : Clupeidae - en entier Potency : 370 milligramme Omega-3 Fatty acids | Not specified | Not calculated |
| Huile de poisson Source : Engraulidae - en entier Potency : 370 milligramme Omega-3 Fatty acids | Not specified | Not calculated |
| Huile de poisson Source : Clupeidae - en entier Potency : 200 milligramme Eicosapentaenoic acid | Not specified | Not calculated |
| Huile de poisson Source : Engraulidae - en entier Potency : 200 milligramme Eicosapentaenoic acid | Not specified | Not calculated |
Non-medicinal ingredients
Gélatine, Eau purifiée, Glycérine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes et adolescents | minimum: 12 years | 1 Capsule | 2 Tous les jours |
| Adultes | Not specified | 3 Capsule | 2 Tous les jours |
| Enfants et Adolescents | minimum: 6 years ; maximum: 12 years | 1 Capsule | 2 Tous les jours |
| Adultes | Not specified | 2 Capsule | 2 Tous les jours |
| Adults (rheumatoid arthritis) | Not specified | 5 Capsule | 2 days |
Uses authorised in Canada
Text supplied in English because no French text is available.
(1) Source of omega-3 fatty acids for the maintenance of good health. (2) Source of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) for the maintenance of good health. (3) Helps maintain/support cardiovascular health. (4) Helps support cognitive health and/or brain function. (5) Helps support the development of the brain, eyes and nerves in children up to 12 years of age. (6) Helps to reduce serum triglycerides/triacylglycerols. (7) Helps to promote healthy mood balance. (8) In conjunction with conventional therapy, helps to reduce the pain of rheumatoid arthritis in adults.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80068622
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2017. Photograph the packaging to check whether it has changed. Photograph the packaging